Themis Medicare Ltd (THEMISMED) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 469937, "name": "Themis Medicare", "stock_name": "Themis Medicare", "full_name": "Themis Medicare Ltd", "name_url": "stocks-analysis/themis-medicare", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "104.25", "chg": 4.05, "chgp": "4.04%", "dir": 1, "prev_price": "100.20", "mcapval": "951.00 Cr", "mcap": "Micro Cap", "scripcode": 530199, "symbol": "THEMISMED", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE083B01024", "curr_date": "Jun 12, 03:30 PM", "curr_time": "05:33 AM", "last_traded_at": "Jun 12, 03:30 PM IST", "bse_nse_vol": "41.05 k", "exc_status": "Active", "traded_date": "Jun 12, 2026", "traded_date_str": "2026 06 12", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/themis-medicare-469937-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Themis Medicare Ltd is Rated Sell by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/themis-medicare-ltd-is-rated-sell-by-marketsmojo-4048860", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ThemisMedicareL_mojoScore_4048860.png", "date": "2026-06-12 10:10:41", "description": "Themis Medicare Ltd is rated Sell by MarketsMOJO, with this rating last updated on 06 April 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 12 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing." }, { "title": "Themis Medicare Ltd is Rated Sell by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/themis-medicare-ltd-is-rated-sell-by-marketsmojo-4026087", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ThemisMedicareL_mojoScore_4026087.png", "date": "2026-06-01 10:10:35", "description": "Themis Medicare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 June 2026, providing investors with an up-to-date view of the company’s performance and outlook." }, { "title": "Themis Medicare Gains 9.25%: Profitability Surge Amid Revenue Challenges", "link": "https://www.marketsmojo.com/news/stocks-in-action/themis-medicare-gains-925-profitability-surge-amid-revenue-challenges-4023508", "imagepath": "", "date": "2026-05-30 17:10:03", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>May 25:</strong> Stock dips 0.74% amid broad Sensex rally</p>\n <p><strong>May 26:</strong> Sharp 6.37% gain on heavy volume</p>\n <p><strong>May 27:</strong> Further 6.87% rise as quarterly results approach</p>\n <p><strong>May 29:</strong> Profitability rebound reported; stock closes down 3.18%</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.100.63</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.109.94</div><div class=\"stat-ch..." }, { "title": "Are Themis Medicare Ltd latest results good or bad?", "link": "https://www.marketsmojo.com/news/result-analysis/are-themis-medicare-ltd-latest-results-good-or-bad-4021878", "imagepath": "", "date": "2026-05-29 19:45:58", "description": "Themis Medicare Ltd's latest financial results present a complex picture of the company's operational performance. In the quarter ending March 2026, the company reported consolidated net profit of ₹8.89 crores, marking a return to profitability after a challenging year-ago period characterized by losses. However, this profit reflects a sequential decline of 11.89% compared to the previous quarter. \n\nNet sales for the same quarter amounted to ₹76.53 crores, which represents a significant sequential contraction of 15.09% from ₹90.13 crores in December 2025, although it shows a year-on-year improvement of 6.74% from ₹71.70 crores in March 2025. This decline in sales raises concerns about the company's ability to sustain operational momentum.\n\nThe operating margin, excluding other income, compressed sharply to 4.91%, down from 10.86% in the previous quarter, indicating potential operational challenges and prici..." }, { "title": "Themis Medicare Ltd Reports Positive Financial Trend Amid Mixed Quarterly Results", "link": "https://www.marketsmojo.com/news/stocks-in-action/themis-medicare-ltd-reports-positive-financial-trend-amid-mixed-quarterly-results-4020262", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ThemisMedicareL_fintrenddot_4020262.png", "date": "2026-05-29 11:01:45", "description": "Themis Medicare Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has demonstrated a notable shift in its financial trajectory for the quarter ended March 2026. Despite a decline in net sales, the company posted significant profit growth, signalling a positive change in its financial trend after a period of stagnation." }, { "title": "Themis Medicare Q4 FY26: Profitability Rebounds but Revenue Concerns Persist", "link": "https://www.marketsmojo.com/news/result-analysis/themis-medicare-q4-fy26-profitability-rebounds-but-revenue-concerns-persist-4020527", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ThemisMedicare_quaterlyResult_4020527.png", "date": "2026-05-29 09:38:46", "description": "Themis Medicare Ltd., a micro-cap pharmaceutical company with a market capitalisation of ₹1,055.47 crores, has posted a consolidated net profit of ₹8.89 crores for Q4 FY26 (Mar'26 quarter), marking an 11.89% sequential decline from ₹10.09 crores in Q3 FY26 but a dramatic turnaround from a loss of ₹9.66 crores in the year-ago quarter. The stock has responded positively to recent trading momentum, gaining 13.88% over the past week to close at ₹114.60 on May 29, 2026, though it remains 18.14% below its level from a year ago." }, { "title": "When is the next results date for Themis Medicare Ltd?", "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-themis-medicare-ltd-4017548", "imagepath": "", "date": "2026-05-27 23:17:19", "description": "The next results date for Themis Medicare Ltd is scheduled for 28 May 2026...." }, { "title": "Themis Medicare Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/themis-medicare-ltd-is-rated-sell-4002668", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ThemisMedicareL_mojoScore_4002668.png", "date": "2026-05-21 10:10:58", "description": "Themis Medicare Ltd is rated Sell by MarketsMOJO, with this rating last updated on 06 Apr 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 21 May 2026, providing investors with the latest insights into its performance and outlook." }, { "title": "Themis Medicare Ltd is Rated Sell by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/themis-medicare-ltd-is-rated-sell-by-marketsmojo-3983927", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ThemisMedicareL_mojoScore_3983927.png", "date": "2026-05-10 10:10:37", "description": "Themis Medicare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing." } ], "total": 291, "sid": "469937", "stock_news_url": "https://www.marketsmojo.com/news/No announcements on in the last one month-469937" }, "announcements": [ { "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance", "datetime": "29-May-2026", "details": "Annual Secretarial Compliance Report for the financial year ended 31st March 2026", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "29-May-2026", "details": "Newspaper Publication of Audited Standalone and Consolidated Financial Results for the quarter and year ended 31.03.2026", "source": "BSE" }, { "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Dated 28Th May 2026", "datetime": "28-May-2026", "details": "1. Approved the Audited Standalone and Consolidated Financial Results for the quarter and year ended 31st March 2026 together with the Report issued by the Statutory Auditors M/s. Krishaan & Co. Chartered Accountants which are attached herewith. 2. Recommended final dividend of Re. 0.50 i.e. @ 50 % per equity share having face value of Re.1/- each aggregating to Rs. 46050060 /- for the Financial Year ended 31st March 2026 subject to the approval of shareholders at the forthcoming Annual General Meeting. 3. Appointment of M/s. R. Nanabhoy & Co. Cost Accountants (FRN - 000011) as the Cost Auditor of the Company for the Financial Year Financial Year 2026-27.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Themis Medicare Ltd has declared <strong>50%</strong> dividend, ex-date: 04 Sep 25", "dt": "2025-09-04", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "", "data": [ { "txt": "Themis Medicare Ltd has announced <strong>1:10</strong> stock split, ex-date: 10 Oct 23", "dt": "2023-10-10", "middle_text": "Split" } ] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

May 25: Stock dips 0.74% amid broad Sensex rally

May 26: Sharp 6.37% gain on heavy volume

May 27: Further 6.87% rise as quarterly results approach

May 29: Profitability rebound reported; stock closes down 3.18%

Read full news article

Are Themis Medicare Ltd latest results good or bad?

2026-05-29 19:45:58

Themis Medicare Ltd's latest financial results present a complex picture of the company's operational performance. In the quarter ending March 2026, the company reported consolidated net profit of ₹8.89 crores, marking a return to profitability after a challenging year-ago period characterized by losses. However, this profit reflects a sequential decline of 11.89% compared to the previous quarter. Net sales for the same quarter amounted to ₹76.53 crores, which represents a significant sequential contraction of 15.09% from ₹90.13 crores in December 2025, although it shows a year-on-year improvement of 6.74% from ₹71.70 crores in March 2025. This decline in sales raises concerns about the company's ability to sustain operational momentum. The operating margin, excluding other income, compressed sharply to 4.91%, down from 10.86% in the previous quarter, indicating potential operational challenges and prici...

Read full news article

Themis Medicare Ltd Reports Positive Financial Trend Amid Mixed Quarterly Results

2026-05-29 11:01:45

Themis Medicare Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has demonstrated a notable shift in its financial trajectory for the quarter ended March 2026. Despite a decline in net sales, the company posted significant profit growth, signalling a positive change in its financial trend after a period of stagnation.

Read full news article

Themis Medicare Q4 FY26: Profitability Rebounds but Revenue Concerns Persist

2026-05-29 09:38:46

Themis Medicare Ltd., a micro-cap pharmaceutical company with a market capitalisation of ₹1,055.47 crores, has posted a consolidated net profit of ₹8.89 crores for Q4 FY26 (Mar'26 quarter), marking an 11.89% sequential decline from ₹10.09 crores in Q3 FY26 but a dramatic turnaround from a loss of ₹9.66 crores in the year-ago quarter. The stock has responded positively to recent trading momentum, gaining 13.88% over the past week to close at ₹114.60 on May 29, 2026, though it remains 18.14% below its level from a year ago.

Read full news article

When is the next results date for Themis Medicare Ltd?

2026-05-27 23:17:19

The next results date for Themis Medicare Ltd is scheduled for 28 May 2026....

Read full news article

Themis Medicare Ltd is Rated Sell

2026-05-21 10:10:58

Themis Medicare Ltd is rated Sell by MarketsMOJO, with this rating last updated on 06 Apr 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 21 May 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Themis Medicare Ltd is Rated Sell by MarketsMOJO

2026-05-10 10:10:37

Themis Medicare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article